Marlier S, Raccah D, Disdier P, Molle L, Harle J R, Vialettes B, Weiller P J
Service de médecine interne, hôpital de la Timone, Marseille, France.
Rev Med Interne. 1995;16(3):209-11. doi: 10.1016/0248-8663(96)80693-x.
We report a case of thyrotoxicosis periodic paralysis (TPP), occurring as a complication of a Grave's disease in a 31 year-old Caucasian male. It has been suggested that the membrane Na-K pump was involved in the pathogenesis of this complication. In our patient, before treatment, the activity of erythrocyte Na-K-ATPase was significantly decreased, as compared with healthy subjects (228nmol Pi/mg prot/h versus 298 + 60 nmol Pi/mg prot/h) and went back to normal levels post treatment. The activity of this enzyme seems to be prone to genetics factors as well as environmental ones. This would explain the higher incidence of TPP in male and in asiatic people. However, other reports emphasize the role of Na-K-pump-independent potassium influx, which would be more specific of TPP.
我们报告一例甲状腺毒症性周期性麻痹(TPP),发生在一名31岁的白种男性Graves病患者身上,为该病的并发症。有观点认为,膜钠钾泵参与了这一并发症的发病机制。在我们的患者中,治疗前红细胞钠钾ATP酶的活性与健康受试者相比显著降低(分别为228nmol Pi/mg蛋白/小时和298 + 60nmol Pi/mg蛋白/小时),治疗后恢复到正常水平。该酶的活性似乎既受遗传因素影响,也受环境因素影响。这可以解释TPP在男性和亚洲人群中发病率较高的现象。然而,其他报告强调了非钠钾泵依赖性钾内流的作用,这可能是TPP更具特异性的原因。